Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_assertion wasGeneratedBy ECO_0000203 NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_assertion wasDerivedFrom befree-20150227 NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_assertion SIO_000772 23760401 NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_assertion evidence source_evidence_literature NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.
- NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_assertion description "[Taken together, our findings support the hypotheses that CD44 and CAM-DR contribute to lenalidomide resistance in multiple myeloma, that CD44 should be evaluated as a putative biomarker of sensitivity to lenalidomide, and that ATRA or other approaches that target CD44 may overcome clinical lenalidomide resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946340.RAAWXfDlg_zsgcwQSwyLK5f97n_dR3Hn3HnvNLk30FIjU130_provenance.